Publication

An interchangeable prion-like domain is required for Ty1 retrotransposition

Downloadable Content

Persistent URL
Last modified
  • 09/17/2025
Type of Material
Authors
    Sean L. Beckwith, University of GeorgiaEmily J. Nomberg, University of GeorgiaAbigail C. Newman, University of GeorgiaJeannette V. Taylor, Emory UniversityRicardo C. Guerrero, Emory UniversityDavid J. Garfinkel, University of Georgia
Language
  • English
Date
  • 2023-02-27
Publisher
  • NIH
Publication Version
Copyright Statement
  • The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. 
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 2023
Grant/Funding Information
  • This work was supported by an NIH grant to DJG (R01GM124216) and an NIH Postdoctoral Fellowship to SLB (F32GM139247). This study was also supported by the Robert P. Apkarian Integrated Electron Microscopy Core (RPAIEMC), which is subsidized by the Emory University School of Medicine and the Emory College of Arts and Sciences. Additional support was provided by the Georgia Clinical & Translational Science Alliance of the National Institute of Health under award number UL1TR000454. Some of the data reported here were collected on the JEOL JEM1400 TEM supported by the National Institutes of Health Grant S10 RR025679.
Supplemental Material (URL)
Abstract
  • Retrotransposons and retroviruses shape genome evolution and can negatively impact genome function. Saccharomyces cerevisiae and its close relatives harbor several families of LTR-retrotransposons, the most abundant being Ty1 in several laboratory strains. The cytosolic foci that nucleate Ty1 virus-like particle (VLP) assembly are not well-understood. These foci, termed retrosomes or T-bodies, contain Ty1 Gag and likely Gag-Pol and the Ty1 mRNA destined for reverse transcription. Here, we report a novel intrinsically disordered N-terminal prion-like domain (PrLD) within Gag that is required for transposition. This domain contains amino-acid composition similar to known yeast prions and is sufficient to nucleate prionogenesis in an established cell-based prion reporter system. Deleting the Ty1 PrLD results in dramatic VLP assembly and retrotransposition defects but does not affect Gag protein level. Ty1 Gag chimeras in which the PrLD is replaced with other sequences, including yeast and mammalian prionogenic domains, display a range of retrotransposition phenotypes from wildtype to null. We examine these chimeras throughout the Ty1 replication cycle and find that some support retrosome formation, VLP assembly, and retrotransposition, including the yeast Sup35 prion and the mouse PrP prion. Our interchangeable Ty1 system provides a useful, genetically tractable in vivo platform for studying PrLDs, complete with a suite of robust and sensitive assays, and host modulators developed to study Ty1 retromobility. Our work invites study into the prevalence of PrLDs in additional mobile elements.
Author Notes
Keywords

Tools

Relations

In Collection:

Items